Elaine A. Sarsynski
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Horace Mann Q2 Earnings Call and Insurance Sector Outlook. Horace Mann Educators released its Q2 2026 earnings conference call transcript, providing details on recent performance. The company is also featured in industry outlooks and lists of multiline insurance stocks, highlighting its role in the broader sector. While peer Aflac announced new AI tools, Horace Mann’s news focuses on its own financial results and market position within the insurance industry.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
TriplePoint Venture Growth faces potential further challenges. A recent analysis suggests that TriplePoint Venture Growth may face continued difficulties. This is relevant to Horizon Technology Finance as a peer in the specialty finance sector, where market sentiment can influence broader group performance. The stock currently trades near its 52-week low, with a high dividend yield and a P/E ratio significantly above the sector average.
Transaction History
| GNW | ▲ Buy | Grant | 32,100 | $290K | 5/20/2026 | View on chart |
| HMN | ▲ Buy | Grant | 2,780 | $130K | 5/20/2026 | View on chart |
| GNW | ▲ Buy | Grant | 41,622 | $290K | 5/22/2025 | View on chart |
| HMN | ▲ Buy | Grant | 3,135 | $130K | 5/14/2025 | View on chart |
| GNW | ▲ Buy | Grant | 41,935 | $270K | 5/23/2024 | View on chart |
| HMN | ▲ Buy | Grant | 3,807 | $130K | 5/22/2024 | View on chart |
| HMN | ▲ Buy | Grant | 3,657 | $115K | 5/24/2023 | View on chart |
| GNW | ▲ Buy | Grant | 43,297 | $237K | 5/18/2023 | View on chart |
| HMN | ▲ Buy | Grant | 2,911 | $0 | 5/25/2022 | View on chart |
| HRZN | ▲ Buy | Open Market | 2,000 | $19K | 3/12/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
KBW Downgrades Genworth to Market Perform, Cuts Price Target
Keefe, Bruyette & Woods downgraded Genworth Financial to Market Perform from Outperform, lowering its price target to $10.50. The firm cited Voya Financial as a key reason for the reduced outlook. The stock is currently trading near its 52-week high, with an average analyst target of $11.50.
KBW Downgrades Genworth to Market Perform, Cuts Price Target. Keefe, Bruyette & Woods downgraded Genworth Financial to Market Perform from Outperform, lowering its price target to $10.50. The firm cited Voya Financial as a key reason for the reduced outlook. The stock is currently trading near its 52-week high, with an average analyst target of $11.50.